Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dingli

Showing results (311-320 of 471) with videos related to

Pageof 48
Sort By:
American Journal of Hematology|March 6, 2025
Clinical Outcomes and Treatment Strategies of Adult Transplant-Associated Thrombotic Microangiopathy: External Validation of Harmonizing Definitions and High-Risk CriteriaAldo A Acosta-Medina, Meera Sridharan, Ronald S Go, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 24, 2019
Survival impact of achieving minimal residual negativity by multi-parametric flow cytometry in AL amyloidosisEli Muchtar, Angela Dispenzieri, Dragan Jevremovic, et al.
Leukemia|October 14, 2018
Primary systemic amyloidosis in patients with Waldenström macroglobulinemiaSaurabh Zanwar, Jithma P Abeykoon, Stephen M Ansell, et al.
Leukemia|October 17, 2018
Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of response and patterns of relapseSurbhi Sidana, Nidhi Tandon, Angela Dispenzieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myelomaMartha Q Lacy, Suzanne R Hayman, Morie A Gertz, et al.
Blood Cancer Journal|May 15, 2023
Conditional survival in multiple myeloma and impact of prognostic factors over timeNadine H Abdallah, Alexandra N Smith, Susan Geyer, et al.
Blood Cancer Journal|August 7, 2025
Value of serum-free light chain measurements in response and progression assessment in multiple myeloma with monoclonal protein measurable by electrophoresisElham Askari, Angela Dispenzieri, Francis K Buadi, et al.
American Journal of Hematology|February 10, 2017
Hematology patient reported symptom screen to assess quality of life for AL amyloidosisRahma Warsame, Shaji K Kumar, Morie A Gertz, et al.
Blood Advances|November 13, 2024
Retreatment of multiple myeloma with previously refractory drugsUtkarsh Goel, Charalampos Charalampous, Prashant Kapoor, et al.
American Journal of Hematology|June 11, 2021
Venetoclax for the treatment of multiple myeloma: Outcomes outside of clinical trialsM Hasib Sidiqi, Abdullah S Al Saleh, Shaji K Kumar, et al.
Pageof 48

Showing results (311-320 of 471) with videos related to

Sort By:
Pageof 48
American Journal of Hematology|March 6, 2025
Clinical Outcomes and Treatment Strategies of Adult Transplant-Associated Thrombotic Microangiopathy: External Validation of Harmonizing Definitions and High-Risk CriteriaAldo A Acosta-Medina, Meera Sridharan, Ronald S Go, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 24, 2019
Survival impact of achieving minimal residual negativity by multi-parametric flow cytometry in AL amyloidosisEli Muchtar, Angela Dispenzieri, Dragan Jevremovic, et al.
Leukemia|October 14, 2018
Primary systemic amyloidosis in patients with Waldenström macroglobulinemiaSaurabh Zanwar, Jithma P Abeykoon, Stephen M Ansell, et al.
Leukemia|October 17, 2018
Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of response and patterns of relapseSurbhi Sidana, Nidhi Tandon, Angela Dispenzieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myelomaMartha Q Lacy, Suzanne R Hayman, Morie A Gertz, et al.
Blood Cancer Journal|May 15, 2023
Conditional survival in multiple myeloma and impact of prognostic factors over timeNadine H Abdallah, Alexandra N Smith, Susan Geyer, et al.
Blood Cancer Journal|August 7, 2025
Value of serum-free light chain measurements in response and progression assessment in multiple myeloma with monoclonal protein measurable by electrophoresisElham Askari, Angela Dispenzieri, Francis K Buadi, et al.
American Journal of Hematology|February 10, 2017
Hematology patient reported symptom screen to assess quality of life for AL amyloidosisRahma Warsame, Shaji K Kumar, Morie A Gertz, et al.
Blood Advances|November 13, 2024
Retreatment of multiple myeloma with previously refractory drugsUtkarsh Goel, Charalampos Charalampous, Prashant Kapoor, et al.
American Journal of Hematology|June 11, 2021
Venetoclax for the treatment of multiple myeloma: Outcomes outside of clinical trialsM Hasib Sidiqi, Abdullah S Al Saleh, Shaji K Kumar, et al.
Pageof 48